How long does stem cell therapy last after an IV infusion?

How long a response to an IV infusion lasts varies from person to person, but it doesn't last forever and it doesn't fade in a month. The usual shape is a peak around weeks 12 to 16, a plateau through month 12 and, for many, a gradual return toward baseline between months 12 and 18.

Book a call → See it month by month

Medically reviewed by the physician team at Hospital Angeles, October 2026

How long does a response last, month by month?

  1. Week 0

    Infusion

    Baseline. Biodistribution begins.

  2. Weeks 1 to 8

    Rising phase

    Some patients report more energy in the first 2 weeks. Other early signals follow: sleep and recovery.

  3. Weeks 12 to 16

    Peak window

    Where the response peaks after a loading infusion.

  4. Months 4 to 12

    Plateau

    Response holds. Stability is the signal. The 6-month review decides what happens next.

  5. Months 12 to 18

    Decay

    For many, a gradual return toward baseline begins. Individual curves vary. This is where maintenance comes up.

The recovery timeline, week by week

Why does it last longer for some people?

  • Baseline inflammation

    Patients with higher baseline inflammatory burden often experience a steeper initial response and a shorter plateau. Patients with lower baseline tend toward a flatter, longer durability curve.

    • CRP / ESR trends
    • Chronic inflammatory load
    • Autoimmune-adjacent profile

  • Lifestyle load

    Sleep, training, nutrition, and stress compound. The better the foundation, the longer the response holds.

    • Sleep duration / quality
    • Training volume & load
    • Metabolic health

  • Age & recovery capacity

    Younger patients with intact recovery biology often see longer plateaus. The decay curve steepens with age.

    • Age decile
    • Hormonal status
    • Resident tissue biology

When does a repeat infusion make sense?

Maintenance is a decision made at follow-up review by the physician team, not a standing subscription. The signal is the response curve, not the calendar. This is why the 6-month review decides what happens next, rather than a schedule set in advance. The response tells us when to intervene again.

When the response is clearly fading, a maintenance infusion is appropriate, and each one builds on the last. When it is holding, you have two honest options: hold and reassess, or, if your goal is to keep building, stack the next dose on the plateau so the gains compound instead of waiting for them to fade. The physician team walks you through both.

  • Clear decay markers

    Symptoms returning. Labs you track on your own trending back toward pre-infusion values. Maintenance is reasonable.

  • Still on plateau

    The response is holding, with no clear decay. Reassess later, or stack a dose on the plateau to build further if maximizing the gain is your goal.

  • Life event or major load

    Surgery, prolonged illness, major training block. Pre-emptive maintenance may make sense, by indication.

Durability questions

What's the longest anyone has held a response?

It varies widely from person to person, and a long plateau from a single dose is not something to plan on. Some patients redose as the response starts to fade, others stack at the plateau to keep building on the gains. The 6-month review decides what happens next.

Can I measure durability objectively?

Partially. Inflammation markers, sleep quality, training-recovery metrics, and symptom-specific tracking give quantitative signals. Many patients re-check their own labs with their own physician, and those results can be passed to the medical team.

What if I'm not feeling anything fade yet at my next review?

You have a choice. We don't infuse on a calendar, so holding and reassessing is always on the table. But a plateau is also a strong base to build on: if your goal is to keep gaining, stacking the next dose while you are still responding compounds the result rather than waiting for it to fade. The physician team lays out both, and the call is yours.

Maintenance, by indication

Follow-up is structured around your actual response. No monthly subscriptions. No pre-scheduled infusions without a clinical reason. The physician team discusses what's realistic for your case during review.

Book a call →

Not medical advice. Individual results vary.